Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiviral”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00905632
What this trial is testing

4 Week Combination of BI 207127 NA With Peg-IFN and Ribavirin in Chronic HCV Patients

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 75
Testing effectiveness (Phase 2)Study completedNCT00546715
What this trial is testing

A Single Ascending Dose Study of Daclatasvir (BMS-790052) in Hepatitis C Virus Infected Subjects

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 95
Testing effectiveness (Phase 2)Study completedNCT01483742
What this trial is testing

Ritonavir-Boosted Danoprevir and RO5024048 in Different Combinations in Null Responder or Treatment-Naïve Patients With Chronic Hepatitis C and Compensated Cirrhosis

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 43
Large-scale testing (Phase 3)Study completedNCT03787459
What this trial is testing

Severe Influenza Trial of ARbidol

Who this might be right for
Influenza
Capital Medical University 200
Early research (Phase 1)Study completedNCT00001062
What this trial is testing

Ganciclovir in the Treatment of Cytomegalovirus of the Eyes

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 25
Testing effectiveness (Phase 2)Study completedNCT00983060
What this trial is testing

Adaptive-design Dose Finding Study to Assess the Antiviral Efficacy and Safety of NIM811 Administered in Combination With Standard of Care (SOC) in Relapsed Hepatitis C Virus 1 (HCV-1) Infected Patients

Who this might be right for
Chronic Hepatitis C Genotype-1 Relapse
Novartis Pharmaceuticals 59
Early research (Phase 1)Study completedNCT04620304
What this trial is testing

Study for Evaluation of the Safety, Pharmacokinetics, and Antiviral Activity of UB-421 Subcutaneous Formulation Administered in HIV-1 Infected Treatment Naive Patients

Who this might be right for
HIV-1 Infection
United BioPharma 15
Testing effectiveness (Phase 2)Study completedNCT02468115
What this trial is testing

Influenza Challenge Study of VIS410 in Healthy Volunteers

Who this might be right for
Influenza
Visterra, Inc. 46
Not applicableUnknownNCT04662138
What this trial is testing

Safety and Efficacy of Different Antiviral Regimens for Hepatitis C Virus Relapse

Who this might be right for
Hepatitis CRelapseAntivirals
Alexandria University 100
Early research (Phase 1)Study completedNCT04386876
What this trial is testing

Bioequivalence Study of Lopinavir/Ritonavir 200/50 mg Film Tablet (World Medicine Ilac, Turkey) Under Fasting Conditions

Who this might be right for
Bioequivalence
World Medicine ILAC SAN. ve TIC. A.S. 30
Post-approval studies (Phase 4)UnknownNCT04034368
What this trial is testing

A Perspective Study of the Antiviral Efficacy and Safety of Switching to TAF Treatment in CHB Adults With Suboptimal Response (SOR) and Intolerant to Entecavir

Who this might be right for
HBV
The First Hospital of Jilin University 8
Testing effectiveness (Phase 2)Study completedNCT04334460
What this trial is testing

Safety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized Subjects

Who this might be right for
Sars-CoV-2Covid19
Blade Therapeutics 120
Not applicableEnded earlyNCT03125408
What this trial is testing

Clinical Performance Evaluation of DxN HCV Assay

Who this might be right for
Hepatitis C
Beckman Coulter, Inc. 210
Post-approval studies (Phase 4)Study completedNCT01439776
What this trial is testing

Add Vitamin D With Standard of Care for Chronic Hepatitis C Patients

Who this might be right for
Chronic Hepatitis C
Hanyang University 180
Testing effectiveness (Phase 2)Study completedNCT01935635
What this trial is testing

A Clinical Trial on HB-Vac Activated-DCs Combined With Peg-IFN or NAs in CHB

Who this might be right for
Chronic Hepatitis B
Third Affiliated Hospital, Sun Yat-Sen University 400
Testing effectiveness (Phase 2)Study completedNCT00002435
What this trial is testing

Thymic Humoral Factor (THF Gamma 2) in HIV-Infected Patients

Who this might be right for
HIV Infections
Pharmacia
Early research (Phase 1)Study completedNCT00646776
What this trial is testing

Drug Interaction Study

Who this might be right for
Antivirals/HIV
Bristol-Myers Squibb 85
Early research (Phase 1)Study completedNCT01740791
What this trial is testing

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Velpatasvir in Participants With Chronic HCV Infection

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 103
Early research (Phase 1)Ended earlyNCT01651767
What this trial is testing

Study in HCV-Infected Patients to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of JNJ-47910382

Who this might be right for
Chronic Hepatitis C Infection
Janssen R&D Ireland 11
Testing effectiveness (Phase 2)Ended earlyNCT00362700
What this trial is testing

Safety and Efficacy Study of Retreated Clevudine in Chronic HBV Patients Who Received Clevudine in L-FMAU-201

Who this might be right for
Hepatitis B
Bukwang Pharmaceutical 33
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation